Authors: Raedler, TJ Knable, MB Jones, DW Lafargue, T Urbina, RA Egan, MF Pickar, D Weinberger, DR

Citation: Tj. Raedler et al., In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia, NEUROPSYCH, 23(1), 2000, pp. 56-68

Authors: Sanfilipo, M Lafargue, T Arena, L Rusinek, H Kushner, K Lautin, A Loneragan, C Vaid, G Rotrosen, J Wolkin, A

Citation: M. Sanfilipo et al., Fine volumetric analysis of the cerebral ventricular system in schizophrenia: Further evidence for multifocal mild to moderate enlargement, SCHIZO BULL, 26(1), 2000, pp. 201-216

Authors: Lafargue, T Brasic, J

Citation: T. Lafargue et J. Brasic, Neurodevelopmental hypothesis of schizophrenia: a central sensory disturbance, MED HYPOTH, 55(4), 2000, pp. 314-318

Authors: Sanfilipo, M Lafargue, T Rusinek, H Arena, L Loneragan, C Lautin, A Feiner, D Retrosen, J Wolkin, A

Citation: M. Sanfilipo et al., Volumetric measure of the frontal and temporal lobe regions in schizophrenia - Relationship to negative symptoms, ARCH G PSYC, 57(5), 2000, pp. 471-480

Authors: Raedler, TJ Knable, MB Lafargue, T Urbina, RA Egan, MF Pickar, D Weinberger, DR

Citation: Tj. Raedler et al., In vivo determination of striatal dopamine D-2 receptor occupancy in patients treated with olanzapine, PSYCH RES-N, 90(2), 1999, pp. 81-90

Authors: Breier, AF Malhotra, AK Su, TP Pinals, DA Elman, I Adler, CM Lafargue, T Clifton, A Pickar, D

Citation: Af. Breier et al., Clozapine and risperidone in chronic schizophrenia: Effects on symptoms, parkinsonian side effects, and neuroendocrine response, AM J PSYCHI, 156(2), 1999, pp. 294-298